Ramona Businger

Boehringer Ingelheim (Germany)

Papers

1

Total Citations

30

H-Index

1

About

Ramona Businger is a virologist whose work focuses on advancing methods for characterizing and quantifying virus-based therapeutics. Her key research areas include viral vector production, infectivity assays, and the development of automated, high-throughput analytical tools for gene therapy and vaccine development. Businger’s most notable contribution is the introduction of a label-free, automated TCID50 assay, which provides a robust and reproducible method for determining the infectious titer of virus-based therapeutics. This innovation addresses a critical bottleneck in the manufacturing and quality control of viral vectors, replacing labor-intensive, manual procedures with a streamlined, objective approach. Her work on this assay, published in 2021, has already garnered 30 citations, reflecting its immediate relevance and adoption by the field. Businger’s research is instrumental in bridging the gap between laboratory-scale production and clinical-grade manufacturing, supporting the safe and efficient development of viral-based treatments for genetic disorders and infectious diseases. Her contributions are particularly valuable for researchers and students working in virology, bioprocessing, and gene therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
Automated, label-free TCID50 assay to determine the infectious titer of virus-based therapeutics
30 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Boehringer Ingelheim (Germany)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago